Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-22

Clinical Trial Update: Phase III Clinical Trial of Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell) [Phase 3]

View source ↗

Summary

Phase 3 trial of Sabin strain inactivated poliovirus vaccine (Vero cell) for poliomyelitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell) (Inactivated poliovirus vaccine (Sabin strain, Vero cell-based))

Snippet

Sponsor: Beijing Minhai Biotechnology Co., Ltd | Conditions: Poliomyelitis | Phase 3 | Status: COMPLETED